Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas

NCT01329900 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: Ofatumumab
DRUG: Ifosfamide
DRUG: Etoposide
DRUG: Mesna
DRUG: G-CSF
PROCEDURE: Stem Cell Collection

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]